Stem cell treatment therapy can be very helpful in relieving symptoms of pain as well as other conditions. Studies confirm some trials have seen success following stem cell treatment therapy. Patients have experienced fast improvement with continued recovery as healing progresses. Patients’ recovery time can vary depending on the condition but the series of treatments improve the results over time.
Our process uses adult stem cells from our large FDA equivalent (COFEPRIS) compliant stem cell bank, harvested Wharton's Jelly (susbtantia gelatinea funicili umbilicalis) which is a gelatinous substance within the umbilical cord largely made up of mucopolysaccharides) (hyaluronic acid and chondroitin sulfate). Stem Cells in Wharton's Jelly express specific genes, including telomerase, which aids in longevity and renewal of stem cells. They can be extracted easily within a lab setting. This stem cells are readily available, efficient, effective and non-invasive. A huge advantage of these cells in the treatment of orthopedic conditions is that they are cultured in a low oxygen environment which makes them more resilient potent and effective with a better metabolic rate than those kept in a normal oxygen environment. This has been found to be an abundant source of pluri-potent mesenchymal stem cells that have been found to cause no negative interaction, rejection scenario or graft vs host disease and have in fact been found to be as effective and efficient as adipose derived stem cells with the added advantage of not submitting our patients to a surgical procedure that can potentially cause pain and is susceptible to infection during recovery. These cells afford us the advantage of not being subject to an unknown quantity of cells that can be extracted from a patient's own fat and therefore gives us complete control over the amount of cells we implant in any given patient..
Heart conditions are one of the most difficult to treat with stem cells. With our stem cell treatment for congestive heart failure method, we are able to get to the affected areas directly delivering the cells into the heart wall and not just the bloodstream.
Stem cells are implanted through a catheter from the right femoral artery up through the aorta into the left ventricle of the heart using a retractable syringe that injects the stem cells directly into the heart wall. Using real-time imaging during the procedure with both a fluoroscope and a tran-esophageal echo-cardigram, we get a complete visual of every portion of the heart and its movement, and wall thickness. The cells will do their job of repairing and restoring the damaged tissue directly as opposed of just being released into the bloodstream.
Dr. Parcero is our board-certified interventional cardiologist that implements these procedures with over 14,000 catherizations completed. He is one of the most respected and top cardiologist in the country. To determine a patient’s candidacy for the stem cell treatment for congestive heart failure, we require the following recent medical records:
Instituto de Medicina Regenerativa (IMR) has been serving patients since 2009. Instituto de Medicina Regenerativa (IMR) began their practice with the knowledge that adipose-derived adult autologous stem cells had the potential to help the body regenerate. It was with a great deal of excitement that they began to offer the option of adult stem cells to seriously ill patients from around the globe. With board-certified specialists taking lead in every case, IMR developed 27 disease specific research protocols, submitting them for both IRB and government approval.
Through these experiences, IMR learned that not every condition could be treated as successfully as others. “It is important that a patient be able to have confidence in his doctor,” said Dr. Javier Lopez, Director of IMR. “Our board of directors represents cutting edge researchers and physicians from around the world. The reason we sought a board with such a strong pedigree is that we wanted to be held to the highest possible standards. When a protocol is successful we want to build upon it. When one does not work well, we seek to learn everything we can from it so that the greatest number of patients will benefit.”